Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma
Blood Cancer Talks
00:00
The Rapid Accrual of the Volumab Trial
I think it's a good example of how to design these cooperative group trials because I think simplicity is the number one criteria for rapid accrual and having an interesting question. It's a standard treatment with the BVAVD and the NEBOAVD has exactly the same schedule people are very familiar with using the Volumab. The combination of the the children's oncology group and the adult cooperative group so this study only went down to 12 we're kind of working on the next study, but pediatricians are very interested in dropping that age probably to even five in terms of including those kids in studies.
Transcript
Play full episode
